HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析

◆英語タイトル:HealthEquity Inc (HQY) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH224068FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HealthEquity Inc (HealthEquity) is a healthcare service provider that offers health savings management services. The company provides integrated health accounts such as health savings account, health reimbursement arrangements, flexible spending accounts for health plans, and health incentive accounts. HealthEquity also offers health reimbursement and flexible spending arrangements solutions; financial advisory services, COBRA administration solutions, direct billing services, and employee retirement income plans. The company provides a supported health account solution to its members with medical and pharmacy claims. HealthEquity is headquartered in Draper, Utah, the US.

HealthEquity Inc Key Recent Developments

Mar 15,2021: HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2021 Financial Results
Jan 11,2021: HealthEquity announces year-endsales outlook, presentation at JP Morgan Healthcare Conference
Dec 04,2020: HealthEquity expands board of directors
Sep 08,2020: HealthEquity reports second quarter results, raises WageWorks synergy target
Jul 08,2020: HealthEquity announces commencement of proposed offering of common stock

This comprehensive SWOT profile of HealthEquity Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of HealthEquity Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

HealthEquity Inc – Key Information
HealthEquity Inc – Overview
HealthEquity Inc – Key Employees
HealthEquity Inc – Key Employee Biographies
HealthEquity Inc – Key Operational Heads
HealthEquity Inc – Major Products and Services
HealthEquity Inc – History
HealthEquity Inc – Company Statement
HealthEquity Inc – Locations And Subsidiaries
HealthEquity Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

HealthEquity Inc – Business Description
HealthEquity Inc – Corporate Strategy
HealthEquity Inc – SWOT Analysis
SWOT Analysis – Overview
HealthEquity Inc – Strengths
HealthEquity Inc – Weaknesses
HealthEquity Inc – Opportunities
HealthEquity Inc – Threats
HealthEquity Inc – Key Competitors

Section 3 – Company Financial Performance Charts

HealthEquity Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

HealthEquity Inc, Key Information
HealthEquity Inc, Key Ratios
HealthEquity Inc, Share Data
HealthEquity Inc, Major Products and Services
HealthEquity Inc, History
HealthEquity Inc, Key Employees
HealthEquity Inc, Key Employee Biographies
HealthEquity Inc, Key Operational Heads
HealthEquity Inc, Other Locations
HealthEquity Inc, Subsidiaries
HealthEquity Inc, Key Competitors
HealthEquity Inc, SWOT Analysis
HealthEquity Inc, Ratios based on current share price
HealthEquity Inc, Annual Ratios
HealthEquity Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lohmann & Rauscher GmbH & Co. KG:企業の戦略的SWOT分析
    Lohmann & Rauscher GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Deutsche Postbank AG:企業の戦略・SWOT・財務情報
    Deutsche Postbank AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Postbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Thor Mining Plc (THR):企業の財務・戦略的SWOT分析
    Summary Thor Mining Plc (Thor Mining) is a mining and mineral exploration and development company. The company carries out acquisition, exploration and develops gold, tungsten and molybdenum properties. Its projects include Molyhil Tungsten and Molybdenum, Spring Hill Gold, Dundas Gold project, and …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析
    Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • ABC Supply Co. Inc.:企業のM&A・事業提携・投資動向
    ABC Supply Co. Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ABC Supply Co. Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Turkiye Garanti Bankasi AS:戦略・SWOT・企業財務分析
    Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Basellandschaftliche Kantonalbank:企業の戦略・SWOT・財務分析
    Basellandschaftliche Kantonalbank - Strategy, SWOT and Corporate Finance Report Summary Basellandschaftliche Kantonalbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Trustco Group Holdings Limited:企業の戦略・SWOT・財務情報
    Trustco Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Trustco Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • 21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Corvia Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc, is a medical device company that offers treatment of heart failure with structural heart devices. The company’s interatrial shunt device (IASD), a trans-catheter device and non-surgical medical device, is designed to treat diastolic heart …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Oxtex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxtex Ltd (Oxtex), formerly Oxtexs Ltd is a medical device company that offers novel self inflating tissue expansion and medical devices. The company’s products include implantable self-inflating tissue expanders that are suitable for specific needs of the clinician and the patient. It uses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆